Found: 3
Select item for more details and to access through your institution.
Real-World Safety and Efficacy of Ombitasvir/ Paritaprevir/Ritonavir/+Dasabuvir±Ribavirin (OBV/PTV/r/+DSV±RBV) Therapy in Recurrent Hepatitis C Virus (HCV) Genotype 1 Infection Post-Liver Transplant: AMBER-CEE Study.
- Published in:
- Annals of Transplantation, 2017, v. 22, p. 199, doi. 10.12659/AOT.903535
- By:
- Publication type:
- Article
Direct-Acting Antivirals Ombitasvir / Paritaprevir / Ritonavir + Dasabuvir with or Without Ribavirin in Hepatitis C Virus (HCV) Genotype 1-Infected Treatment-Naive or Treatment-Experienced Patients with or Without Cirrhosis: Real-Life Experience in Lithuania and Latvia.
- Published in:
- Hepatitis Monthly, 2018, v. 18, n. 1, p. 1, doi. 10.5812/hepatmon.62105
- By:
- Publication type:
- Article
Quantitative Assessment of Liver Impairment in Chronic Viral Hepatitis with [ 99m Tc]Tc-Mebrofenin: A Noninvasive Attempt to Stage Viral Hepatitis-Associated Liver Fibrosis.
- Published in:
- Medicina (1010660X), 2022, v. 58, n. 10, p. 1333, doi. 10.3390/medicina58101333
- By:
- Publication type:
- Article